Comparison of Bariatric Surgery and Glucagon-Like Peptide-1 Analogs for Prevention of Nonalcoholic Fatty Liver Disease in an Obese Population: A Large Multi-Center Study

被引：0
|
作者：
Cohen, Ethan M. [1 ]
Adekolu, Ayowumi A. [1 ]
Maan, Soban A. [1 ]
Foryoung, Joyce [1 ]
Thakkar, Shyam [1 ]
Singh, Shailendra [1 ]
机构：
[1] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1652
引用
收藏
页码：S1237 / S1237
页数：1
相关论文
共 50 条
  • [31] USE OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS IN KIDNEY TRANSPLANT PATIENTS: A MULTI-CENTER STUDY
    Vigara Sanchez, Luis Alberto
    Villanego Fernandez, Florentino
    Orellana, Cristhian
    Eady Alonso, Myriam
    Sanchez Marquez, Maria Gabriela
    Garcia Jimenez, Maria Belen
    Alonso, Marta
    Manuel Amaro, Jose
    Garcia, Teresa
    Mazuecos, Auxiliadora
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I933 - I934
  • [32] Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet
    Jin, Miaomiao
    Niu, Xiaohong
    Liu, Yan
    Zhang, Dong
    Yuan, Danni
    Shen, Huimin
    OPEN MEDICINE, 2020, 15 (01): : 689 - 696
  • [33] Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists
    Patoulias, Dimitrios
    Kalogirou, Maria-Styliani
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Doumas, Michael
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (09): : 648 - 649
  • [34] Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
    Yabut, Julian M.
    Drucker, Daniel J.
    ENDOCRINE REVIEWS, 2023, 44 (01) : 14 - 32
  • [35] Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery
    Samuels, Jason M.
    Niswender, Kevin D.
    Roumie, Christianne L.
    Spann, Matthew D.
    Flynn, C. Robb
    Ye, Fei
    Blankush, Joseph
    Irlmeier, Rebecca
    Funk, Luke M.
    Patel, Mayur B.
    DIABETES OBESITY & METABOLISM, 2024, 26 (09): : 3906 - 3913
  • [36] Glucagon and glucagon-like peptide-1 dual agonist therapy: A possible future towards fatty kidney disease
    Kanbay, Mehmet
    Copur, Sidar
    Guldan, Mustafa
    Ozbek, Lasin
    Mallamaci, Francesca
    Zoccali, Carmine
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2025, 55 (01)
  • [37] Use of thiazolidinediones and glucagon-like peptide-1 receptor agonists and the risk of non-alcoholic fatty liver disease
    Driessen, Johanna H. M.
    van Dalem, Judith
    Burden, Andrea M.
    Stehouwer, Coen D. A.
    Klungel, Olaf H.
    de Vries, Frank
    Brouwers, Martijn C. G. J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 128 - 128
  • [38] Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease
    Al-Sabah, Salman
    Al-Khairi, Irina
    Jamal, Mohammad
    Qaddoumi, Mohammad
    Alajmi, Fahad
    Kumar, Jijin
    Abukhalaf, Nermeen
    Cherian, Preethi
    Madhu, Dhanya
    Arefanian, Hossein
    Dsouza, Carol
    Alam-Eldin, Nada
    Alsabagh, Abdullah
    Al Madhoun, Ashraf
    Al-Sabah, Suleiman
    Al-Mulla, Fahd
    Abu-Farha, Mohamed
    Abubaker, Jehad
    MEDICAL PRINCIPLES AND PRACTICE, 2024, 33 (05) : 478 - 490
  • [39] Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease-Current Background, Hopes, and Perspectives
    Cazac, Georgiana-Diana
    Lacatusu, Cristina-Mihaela
    Stefanescu, Gabriela
    Mihai, Catalina
    Grigorescu, Elena-Daniela
    Onofriescu, Alina
    Mihai, Bogdan-Mircea
    METABOLITES, 2023, 13 (05)
  • [40] Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists reply
    Walus-Miarka, Malgorzata
    Kapusta, Maria
    Miarka, Przemyslaw
    Trojak, Aleksandra
    Idzior-Walus, Barbara
    Malecki, Maciej T.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (09): : 649 - 650
12345